Home Tools
Log in
Cart

Search Result

Search Results for " p-cab "

10

Compounds

Cat No. Product Name Synonyms Targets
T62316 P-CAB agent 1
P-CAB agent 1 (compound B19) is a potassium-competitive acid blocker that acts on H+/K+-ATPase (IC50: 60.50 nM). P-CAB agent 1 can be used in the study of acid-related diseases (ARDs).
T72897 P-CAB agent 2
P-CAB Agent 2 is a potent, orally active potassium-competitive acid blocker (P-CAB) and gastric acid secretion inhibitor that effectively inhibits H+/K+-ATPase activity, showing an IC50 value of <100 nM. It also demonstr...
T72181 P-CAB agent 2 hydrochloride
P-CAB agent 2 hydrochloride is a potent, orally active potassium-competitive acid blocker (P-CAB) and gastric acid secretion inhibitor. It effectively inhibits H+/K+-ATPase activity, with an IC50 value of <100 nM, and ta...
T8388 Vonoprazan TAK-438 (free base) Proton pump
Vonoprazan (TAK-438 (free base)) is an orally active potassium-competitive acid blocker.Vonoprazan can be used for the treatment of gastroduodenal ulcer and reflux esophagitis
T21254 Vonoprazan Fumarate TAK-438,TAK 438,Vonoprazan Fumurate,TAK438 Proton pump
Vonoprazan Fumarate (TAK438) , a novel potassium-competitive acid blocker, inhibits gastric acid secretion. Vonoprazan Fumarate (TAK438) inhibited H+,K+-ATPase activity in porcine gastric microsomes with IC50 value of 19...
T2404 Vonoprazan fumarate TAK-438 ATPase
Vonoprazan fumarate (TAK-438) is a novel P-CAB (potassium-competitive acid blocker) that reversibly inhibits H+/K+, ATPase.
T2093 PF 03716556 PF-3716556 ATPase
PF 03716556 (PF-3716556) , an effective and specific P-CAB (potassium-competitive acid blocker), is utilized for the treatment of gastroesophageal reflux disease.
T2405 Revaprazan hydrochloride YH1885 ATPase , COX , Antibacterial
Revaprazan hydrochloride (YH1885) is the hydrochloride salt form of a lipophilic, weak base with potassium-competitive acid blocking (P-CAB) activity.
T69613 Ar-H047108 free base
Ar-H047108 free base is an imidazopyridine potassium competitive acid blocker (P-CAB). This drug may be used to treat early stellate cell activation and veno-occlusive-disease (VOD)-like hepatotoxicity.
T61643 Vonoprazan hydrochloride
Vonoprazan hydrochloride, a proton pump inhibitor (PPI), effectively acts as a potassium-competitive acid blocker (P-CAB) with potent antisecretory activity. It notably inhibits H+,K+-ATPase activity in porcine gastric m...
TargetMol